Press release content from Business Wire. The AP news staff was not involved in its creation. Nuclera Acquires E Ink Digital Microfluidics Unit May 12, 2021 GMT Nuclera desktop bioprinter powered by digital microfluidic technology. (Photo: Business Wire) CAMBRIDGE, UK & BILLERICA, Mass.--(BUSINESS WIRE)--May 12, 2021-- Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of electronic ink technology, are pleased to announce the acquisition of E Ink’s digital microfluidics unit into the newly formed US subsidiary of Nuclera. Combining the technologies of the two companies will enable the delivery of a revolutionary desktop protein and gene “bioprinter” with breakthrough speed and convenience for researchers in human health, agriculture, and other markets of global importance.